Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
  • Peer groups
    • HR Peer Group
    • Recruitment Peer Group
    • Marketing Peer Group
    • PA Peer Group
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job
    • Peer groups
      • HR Peer Group
      • Recruitment Peer Group
      • Marketing Peer Group
      • PA Peer Group

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    5 September 2023

    Revvity unveils next-generation preclinical imaging technologies to help scientists drive breakthrough discoveries

    WALTHAM, Mass., Revvity, Inc. debuts its enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch of three systems. ...

    5 September 2023

    Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

    Offers clinical labs in APAC and Middle East cost-efficient, bench-top robotic cell-free DNA extraction workstation and reagents for Yourgene’s Sage 32 NIPT Workflow. ...

    4 September 2023

    Moving on up: Guardtech Group celebrate continued growth with switch to stunning new home

    Cleanroom construction experts putting finishing touches on impressive new Guardtech House HQ in Haverhill. ...

    4 September 2023

    TherageniX and University of Nottingham Awarded £995K Innovate UK grant to develop powdered gene therapy for bone regeneration

    London, UK, and Nottingham, UK - TherageniX, a University of Nottingham spin out pioneering a dry powder gene therapy formulation for bone graft augmentation, and its collaborator, the University of Nottingham, have been awarded a £995,000 grant from Innovate UK, the UK’s innovation age...

    31 August 2023

    Five ways to combat new job nerves when you hire

    Studies show that 80% of people are nervous before starting a new job. Having spent time and money on the recruitment process, you'll want to make sure your new employees have a smooth onboarding process and hit the ground running as soon as possible. ...

    9 August 2023

    NIHR BioResource - Celebrating our Centres - Birmingham

    The NIHR BioResource Centre Birmingham team have been busy on the ground engaging with local communities at events, talking about the NAFLD BioResource and patient participation on local radio, and getting professional videos made to promote diversity, participation and the value of res...

    7 August 2023

    Living with SANDO – a long road to diagnosis

    42-year-old Mark shares his story living with Sensory Ataxic Neuropathy, Dysarthria, and Ophthalmoparesis (SANDO) disease, a rare mitochondrial condition that affects the brain, muscles, nerves and eyes. He discusses everything from the long road to diagnosis, his brother developing sym...

    31 August 2023

    Optibrium acquires BioPharmics LLC, expanding its 3D drug design and visualisation offering

    BioPharmics’ Drs Ajay Jain (CEO) and Ann Cleves (Director of Applied Science) join the Optibrium team as Vice Presidents in the newly-created BioPharmics Division. ...

    3 August 2023

    NIHR IMID BioResource recruits its 10,000th volunteer in major milestone

    The platform for research into Immune-Mediated Inflammatory Diseases (IMIDs) has now signed up 10,000 participants nationwide. Find out about the value of having such a large cohort and what it means for future research studies into IMIDs. ...

    30 August 2023

    Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

    Cambridge, UK - Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, announces that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 190
    • Page 191
    • Current page 192
    • Page 193
    • Page 194
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS